Up next

Autoplay

FDA Approves Biosimilar to Humira – IBD in the News

1 Views • 08/19/25
Share
Side Effects
Side Effects
Subscribers
0

The FDA recently approved a biosimilar (Amjevita) to Humira, which is indicated for multiple inflammatory diseases, including Crohn’s disease and ulcerative colitis. Dr. Edward Loftus discusses some of the issues surrounding this drug.

Show more
0 Comments sort Sort By

Up next

Autoplay